PolySearch2 - Role of estrogen receptors I+- and I2 in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils.

PolySearch2 - Result Details

(2019) Role of estrogen receptors α and β in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils. Toxicology;Toxicology;2019 01;411:93-100

Recent studies have shown that the estrogen receptor I+- (ERI+-), but not ERI2, is involved in the proinflammatory and propruritic responses in cutaneous allergy. In addition, results from our recent study showed that while oral administration of the rather ERI2-selective agonist Bisphenol A exacerbated the respiratory allergic inflammation, the potential inflammatory reaction in the skin was decreased after administration of Bisphenol A. This study aimed to elucidate whether ERI+- and ERI2 are involved in the progression of an allergic airway inflammation. We performed an in vivo experiment using an animal model of allergic airway inflammation using male BALB/c mice to confirm an increase in the proinflammatory response induced by propylpyrazoletriol (PPT), an ERI+- agonist, and diarylpropionitrile (DPN), an ERI2 agonist. Oral administration of PPT or DPN showed a significant increase in the inflammation of the lung and infiltration of eosinophils. While the expression of Th2 cytokines such as interleukin 4 (IL-4) and IL-13 was not affected by exposure to PPT or DPN, administration of these agonists significantly increased the expression of IL-33. The mechanism underlying the development of such allergic inflammatory responses was determined by an in vitro study using the human bronchial epithelial cell line (BEAS-2B) and the human eosinophilic leukemia cell line (EoL-1). Activated cells were exposed to PPT or DPN for 24ah, and the cytokine levels were measured. The IL-33 levels in BEAS-2B cells increased significantly after exposure to PPT or DPN. In addition, pretreatment with PPT or DPN increased the expression of IL-8 in activated EoL-1 cells. Our findings indicate that ERI+- and ERI2 are involved in the proinflammatory response in respiratory allergy, and their effects may be mediated by an increase in the expression of IL-33 and infiltration of eosinophils.

MEDLINE 30445053 : Role of estrogen receptors I+- and I2 in the development of allergic airway inflammation in mice: A possible involvement of interleukin 33 and eosinophils.

Back to View Evidence Back to View Results View Article on PubMed

Legend

Query Term

Association Word

Drug, Toxin

Gene, Protein, Gene Family, Pathway, SNP

Human Metabolite, Food Metaboilte, MeSH Compound

Tissue, Organ, Subcellular Localization

MeSH Term, Gene Ontology, Chemical Taxonomy, ICD-10 Code

Health Effect, Drug Effect, Adverse Effect

Disease, Species

Please cite:

Liu Y., Liang Y., Wishart D.S. (2015) PolySearch 2.0: A significantly improved text-mining system for discovering associations between human diseases, genes, drugs, metabolites, toxins, and more. Nucleic Acids Res. 2015 Jul 1;43(Web Server Issue):W535-42.

To cite the original version of PolySearch (no longer active), please cite:

Cheng D., Knox C., Young N., Stothard P., Damaraju S., Wishart D.S. (2008) PolySearch: a web-based text mining system for extracting relationships between human diseases, genes, mutations, drugs and metabolites. Nucleic Acids Res. 2008 Jul 1;36(Web Server Issue):W399-405.

This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $900 million in funding from the federal government.